非何杰金氏淋巴瘤
- 网络non-Hodgkin's lymphoma;nHL
![非何杰金氏淋巴瘤](../cache/1192591.jpg)
-
病理类型均为非何杰金氏淋巴瘤,其中B细胞型40例,T细胞型14例。
Their pathological types were all NHL which including 49 cases of B cell lymphoma and 17 cases of T cell lymphoma .
-
方法51例儿童非何杰金氏淋巴瘤患者分成2组:常规化疗+富氧治疗组(A组,31例)和常规化疗组(B组,20例)。
Methods 51 childish patients with NHL were divided into two groups . 31 were treated by combined full oxygen treatment ( group A ) and 20 by normal treatment ( group B ) .
-
美罗华治疗32例弥漫型大B细胞性非何杰金氏淋巴瘤
The therapeutic effects of Rituximab on 32 diffuse large B cell non - Hodgkin lymphoma cases
-
目的探讨骨原发性非何杰金氏淋巴瘤的X线与CT表现及诊断要点。
Objective To research X-ray and CT findings and diagnosis of primary non-Hodgkin lymphoma of the bone .
-
骨原发性非何杰金氏淋巴瘤X线与CT表现探讨(附8例报告)
X-ray and CT Diagnosis of Primary Non-Hodgkin Lymphoma of the Bone ( A Report of 8 Cases )
-
目的:探讨原发性腭扁桃体非何杰金氏淋巴瘤(non-HodgkinLymphoma,NHL)的CT检查及诊断。
Objective : To study the value of CT on the diagnosis of primary non-Hodgkin lymphoma ( NHL ) of palatine tonsil .
-
CHOP方案治疗复发性非何杰金氏淋巴瘤38例近期疗效分析
Treatment of Recurrent Non-Hodgkin 's Lymphoma ( NHL ) With CHOP Regimen-Observation of the Short-term Curative Effect in 38 Cases
-
目的评价美罗华治疗弥漫型大B细胞性非何杰金氏淋巴瘤DLBCL的临床效果及不良反应。
OBJECTIVE To evaluate the therapeutic effects and side - effects of Rituximab on diffuse large B cell non - Hodgkin lymphoma ( DLBCL ) .
-
用免疫球蛋白重链J区(JH),K轻链及λ轻链C区(Ck、Cλ2)基因探针及Southern印迹杂交技术,对22例非何杰金氏淋巴瘤进行分析。
The B-cell clonality of 22 cases of non-Hodgkin 's lymphoma was analysed by using the immunoglobulin JH , CK and C_ λ gene probes and Southern blot hybridization method .
-
材料及方法:分析5例经病理证实的椎管恶性淋巴瘤的MRI表现,其中何杰金氏淋巴瘤(HL)2例,非何杰金氏淋巴瘤(NHL)3例。
Materials and Methods : 5 patients with malignant lymphoma in spinal canal including 2 cases hodgkin lymphoma and 3 cases Non-Hodgkin lymphoma were performed with MRI .
-
微软(MicrosoftCorp.)创始人之一、亿万富豪保罗•艾伦(PaulAllen),本月被诊断出非何杰金氏淋巴瘤,目前正在接受化疗。
Investor Paul Allen Diagnosed With Non-Hodgkin 's Lymphoma Paul Allen , the billionaire investor who co-founded Microsoft Corp. ( MSFT ) , was diagnosed earlier this month with non-Hodgkin 's lymphoma and is undergoing chemotherapy .
-
尽管抗CD20抗体在临床治疗非何杰金氏淋巴瘤上获得了成功,但是其抑制肿瘤的作用机理仍有一定的争议,还需进一步深入研究。
Despite clinical success the exact mechanisms of action of various anti-CD20 antibodies remains mostly unclear , which it is necessary to study further .
-
目的探讨原发性甲状腺非何杰金氏淋巴瘤(PTL)临床特点、诊断措施,治疗的选择及影响局部控制和预后因素。
Objective To discuss the clinical characters , diagnostic measures , the optimal management and to analyze local control and prognosis factors of primary thyroid lymphoma ( PTL ) .
-
57例非何杰金氏淋巴瘤尸检病例的病理分析
Non-Hodgkin 's Lymphoma & A Pathologic Study of 57 Autopsy Cases
-
原发纵隔的非何杰金氏淋巴瘤20例临床分析
Primary Mediastinal Non-Hodgkin 's Lymphornas : A Clinical Study of 20 Patients
-
非何杰金氏淋巴瘤的T细胞受体和免疫球蛋白重链基因重排的初步研究
T Cell Receptor and Immunoglobulin Gene Rearrangement Assays on Non-Hodgkin 's Lymphomas
-
结外非何杰金氏淋巴瘤&附22例报道
Extra-nodal Non-Hodgkin 's Lymphoma . A Report of 22 Cases
-
非何杰金氏淋巴瘤成都分类方案的临床价值
Clinical Value of the Chengdu Classification of Non-Hodgkin 's Lymphomas
-
71例复发性儿童非何杰金氏淋巴瘤临床分析
Clinical Analysis of 71 Cases of Recurrent NHL of Children
-
耳鼻咽喉部非何杰金氏淋巴瘤45例报告
Report of 45 cases of non-hodgkin lymphoma in otorhinolaryngology
-
非何杰金氏淋巴瘤流式细胞分析
Analysis of flow cytometry in non-hodgkin 's lymphomas
-
原发性乳腺鳞癌及非何杰金氏淋巴瘤无特征性表现。
Primary squamous cell carcinoma of breast and NHL have no specific X-ray features .
-
Ⅰ、Ⅱ期扁桃体非何杰金氏淋巴瘤的放射治疗&附69例疗效分析
Radiotherapy of Stage ⅰ And ⅱ Non-Hodgkin 's Lymphoma In Tonsil-Analysis of 69 Patients
-
口腔颌面部非何杰金氏淋巴瘤的放射治疗&附36例分析
Radiotherapy of Non-Hodgkin 's Lymphoma in Oral Cavity and Head & Analysis of 36 Patients
-
富氧治疗对儿童非何杰金氏淋巴瘤患者的抗氧化作用研究
The Effection of Antioxygen by Combined Full Oxygen Treatment in the Childish Patients with NHL
-
本文报告三例原发于脾脏的非何杰金氏淋巴瘤。
This paper reports 3 cases .
-
非何杰金氏淋巴瘤在鼻咽部形成大的肿块,腹腔和后纵隔淋巴结广泛肿大。
NHL developed a nasopharyngeal mass with lymphadenopathy widely extending in abdominal cavity and posterior mediastinum .
-
艾伦,本月被诊断出非何杰金氏淋巴瘤,目前正在接受化疗。
MSFT , was diagnosed earlier this month with non-Hodgkin 's lymphoma and is undergoing chemotherapy .
-
应用CHEP/BOD方案治疗晚期中、高度恶性非何杰金氏淋巴瘤的疗效观察
Chep / bod treatment of stage III and IV intermediate or high grade malignancy non-hodgkin 's lymphoma
-
多项参数对评价非何杰金氏淋巴瘤诊断和细胞活性的意义
The Significance of Various Parameters in the Diagnosis of Non-Hodgkin 's Lymphoma and in Evaluation of Cellular Activity